GlobeStar Therapeutics Corp Quarterly Operating Income (Loss) in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
GlobeStar Therapeutics Corp quarterly/annual Operating Income (Loss) history and growth rate from Q4 2010 to Q2 2024.
  • GlobeStar Therapeutics Corp Operating Income (Loss) for the quarter ending June 30, 2024 was -$193K, a 84.9% increase year-over-year.
  • GlobeStar Therapeutics Corp Operating Income (Loss) for the twelve months ending June 30, 2024 was -$805K, a 57.1% increase year-over-year.
  • GlobeStar Therapeutics Corp annual Operating Income (Loss) for 2023 was -$1.86M, a 47.4% decline from 2022.
  • GlobeStar Therapeutics Corp annual Operating Income (Loss) for 2022 was -$1.27M, a 86.1% increase from 2021.
  • GlobeStar Therapeutics Corp annual Operating Income (Loss) for 2021 was -$9.09M, a 2895% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$805K -$193K +$1.09M +84.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-10-11
Q1 2024 -$1.89M -$168K -$25.5K -18% Jan 1, 2024 Mar 31, 2024 10-Q 2024-06-28
Q4 2023 -$1.87M -$156K -$630 -0.41% Oct 1, 2023 Dec 31, 2023 10-Q 2024-03-12
Q3 2023 -$1.86M -$288K +$12.1K +4.02% Jul 1, 2023 Sep 30, 2023 10-K 2024-01-19
Q2 2023 -$1.88M -$1.28M -$1.14M -836% Apr 1, 2023 Jun 30, 2023 10-Q 2024-10-11
Q1 2023 -$734K -$142K +$520K +78.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-06-28
Q4 2022 -$1.25M -$155K +$11.1K +6.65% Oct 1, 2022 Dec 31, 2022 10-Q 2024-03-12
Q3 2022 -$1.27M -$300K +$3.79M +92.7% Jul 1, 2022 Sep 30, 2022 10-K 2024-01-19
Q2 2022 -$5.05M -$137K +$4.34M +96.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-17
Q1 2022 -$9.39M -$662K -$192K -40.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-31
Q4 2021 -$9.2M -$166K -$106K -176% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-13
Q3 2021 -$9.09M -$4.09M -$3.96M -3055% Jul 1, 2021 Sep 30, 2021 10-K 2023-01-09
Q2 2021 -$5.14M -$4.48M -$4.43M -9121% Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-08-23
Q1 2021 -$709K -$470K -$419K -815% Jan 1, 2021 Mar 31, 2021 10-Q 2022-06-01
Q4 2020 -$290K -$60.4K +$13.9K +18.7% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 -$304K -$129K -$67.7K -109% Jul 1, 2020 Sep 30, 2020 10-K 2022-01-05
Q2 2020 -$236K -$48.6K +$5.3K +9.83% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
Q1 2020 -$241K -$51.4K +$19.4K +27.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-21
Q4 2019 -$261K -$74.2K +$55.2K +42.6% Oct 1, 2019 Dec 31, 2019 10-Q 2021-01-28
Q3 2019 -$316K -$61.8K +$49.1K +44.3% Jul 1, 2019 Sep 30, 2019 10-K 2020-12-03
Q2 2019 -$365K -$53.9K +$15.9K +22.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-14
Q1 2019 -$381K -$70.8K -$29.1K -69.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 -$352K -$129K -$700 -0.54% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-14
Q3 2018 -$351K -$111K -$85.9K -343% Jul 1, 2018 Sep 30, 2018 10-K 2019-12-31
Q2 2018 -$265K -$69.7K +$9.47K +12% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 -$275K -$41.7K +$78.1K +65.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$353K -$129K +$108K +45.7% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-19
Q3 2017 -$461K -$25K Jul 1, 2017 Sep 30, 2017 10-K 2019-01-03
Q2 2017 -$79.2K -$53.9K -213% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 -$120K -$23.5K -24.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 -$237K -$105K -80% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-15
Q2 2016 -$496K -$25.3K +$181K +87.8% Apr 30, 2016 Jun 30, 2016 10-Q/A 2017-08-23
Q1 2016 -$678K -$96.4K +$53.5K +35.7% Jan 1, 2016 Mar 31, 2016 10-Q/A 2016-06-16
Q4 2015 -$731K -$132K -$33.3K -33.9% Oct 1, 2015 Dec 31, 2015 10-Q 2016-02-22
Q3 2015 -$698K -$243K -$197K -428% Jul 1, 2015 Sep 30, 2015 10-K/A 2016-01-22
Q2 2015 -$501K -$207K -$59.8K -40.7% Apr 1, 2015 Jun 30, 2015 10-Q/A 2015-09-24
Q1 2015 -$441K -$150K -$45.1K -43% Jan 1, 2015 Mar 31, 2015 10-Q/A 2016-06-16
Q4 2014 -$396K -$98.2K +$61.7K +38.6% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-22
Q3 2014 -$458K -$46.1K +$283K +86% Jul 1, 2014 Sep 30, 2014 10-K/A 2016-01-22
Q2 2014 -$740K -$147K -$24.9K -20.5% Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-09-24
Q1 2014 -$715K -$105K +$30.5K +22.5% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-09-17
Q4 2013 -$746K -$160K -$101K -170% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 -$645K -$329K -$278K -543% Jul 1, 2013 Sep 30, 2013 10-K/A 2015-01-27
Q2 2013 -$367K -$122K +$600K +83.1% Apr 1, 2013 Jun 30, 2013 10-Q/A 2014-09-04
Q1 2013 -$968K -$135K -$32.4K -31.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-20
Q4 2012 -$935K -$59.1K +$9.62K +14% Oct 1, 2012 Dec 31, 2012 10-Q/A 2014-02-21
Q3 2012 -$945K -$51.1K -$18.7K -57.7% Jul 1, 2012 Sep 30, 2012 10-K/A 2014-01-23
Q2 2012 -$926K -$722K -$705K -4044% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$221K -$103K -$101K -4796% Jan 1, 2012 Mar 31, 2012 10-Q/A 2013-05-16
Q4 2011 -$121K -$68.8K -$66.6K -3098% Oct 1, 2011 Dec 31, 2011 10-Q/A 2013-03-07
Q3 2011 -$54.1K -$32.4K Jul 1, 2011 Sep 30, 2011 10-K/A 2013-03-07
Q2 2011 -$17.4K Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-20
Q1 2011 -$2.1K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q4 2010 -$2.15K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.